Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
27.3M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
20.8M
-
Shares change
-
-1.56M
-
Total reported value, excl. options
-
$45M
-
Value change
-
-$4.17M
-
Put/Call ratio
-
1.56
-
Number of buys
-
37
-
Number of sells
-
-38
-
Price
-
$2.16
Significant Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) as of Q1 2025
99 filings reported holding ANRO - Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.8M shares
of 27.3M outstanding shares and own 76.49% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (3.71M shares), ARMISTICE CAPITAL, LLC (1.6M shares), BlackRock, Inc. (1.46M shares), FMR LLC (1.27M shares), Point72 Asset Management, L.P. (1.24M shares), VANGUARD GROUP INC (1.22M shares), FRANKLIN RESOURCES INC (1.16M shares), Vestal Point Capital, LP (915K shares), AWM Investment Company, Inc. (902K shares), and MARSHALL WACE, LLP (853K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.